Reading size

PACK IN HAND · ONE-PAGE CHECK

Medicine pack check sheet

Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.

Published record starting point

Record display name
MINIPRESS
Generic name / active ingredient
prazosin hydrochloride capsules
Dosage-form class
Prazosin hydrochloride immediate-release oral capsules. The 1, 2 and 5 mg figures are amounts of prazosin per capsule; 90 or 250 is the corresponding number of capsules in a bottle. Current authorised-generic capsules retain Pfizer/Minipress imprints, but the Prasco bottle label is not a current MINIPRESS brand bottle; imprint, brand and packaging cannot be concluded from one field alone.
Route
Oral
Record reviewed
2026-09-04

Copy from the pack in hand

Source-linked reading points

  • Older adults, people living alone, those with falls or night-time rising, and people using another antihypertensive should have the exact pack, blood pressure, dizziness or syncope and full medicine list reviewed; do not use the page to move from 1 mg to 2 mg or 5 mg.
  • The label explains that adding a diuretic, beta blocker or another antihypertensive may increase hypotensive effects. Self-spacing does not prove that risk has disappeared and cannot replace prescriber review.
  • Related alpha blockers and PDE-5 inhibitors may have combined blood-pressure effects. If MINIPRESS, HYTRIN, CARDURA, FLOMAX, RAPAFLO, UROXATRAL, CIALIS or VIAGRA appear on one list, seek review rather than self-alternating or combining them.
  • Syncope, an injurious fall or severe weakness needs timely medical assessment. An erection lasting more than four hours is an FDA-labelled emergency signal requiring immediate local emergency care.

Reviewed presentation examples — compare every field

  • Prazosin 1 mg per capsule; 90-capsule bottle; current authorised genericNDC 66993-431-85
  • Prazosin 2 mg per capsule; 90-capsule bottle; current authorised genericNDC 66993-432-85
  • Prazosin 5 mg per capsule; 90-capsule bottle; current authorised genericNDC 66993-433-85

EDITORIAL RECORD

Who prepared and checked this page

Byline
OriginDrug Content Editorial
Review role
Public primary-source verification
Last reviewed
2026-09-04
Source record
4 clickable primary-source entry points are listed with this dossier.

The review role checks source traceability, stated market, document version and product-identity fields. It is not a claim of clinical licensure, prescribing authority or individual pharmacy service. Read the editorial policy.

Search records
Enlarged public-label image